Stream Link 1 PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1675111&tp_key=b3849baf29
Stream Link 8 PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1675112&tp_key=c1432d3276
This activity is part 3 of a 3-part webinar curriculum and includes a Powered by Patients™ video interview.
Program Description
Pharmacists play vital roles in overseeing medication therapy management, optimizing patient outcomes, and reducing the disease burden for those living with chronic obstructive pulmonary disease (COPD). Their responsibilities in the care of patients with COPD include developing personalized treatment plans and providing clear instructions on proper inhaler technique, medication adherence, and adverse effects. This third webinar in the COPD curriculum will provide pharmacists with practical strategies to address unmet needs for patients with COPD. Tools and insights will be presented to equip pharmacists within the multidisciplinary care team to minimize exacerbations and tailor treatment regimens for patients based on the latest clinical evidence. By leveraging their medication expertise, addressing unmet needs, and fostering collaboration, pharmacists can significantly improve the continuity of care in COPD management and patient outcomes.
Target audience: Specialty, health-system, and retail pharmacists
Type of activity: Application
Release date: August 6, 2024
Expiration date: October 6, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify strategies for pharmacists to reduce the disease burden for patients living with chronic obstructive pulmonary disease (COPD), including addressing the unmet needs of the disease
- Apply evidence from clinical trials to formulate optimal treatment regimens that integrate emerging biologics for patients living with COPD
- Explore the role of the pharmacist on the multidisciplinary care team to optimize patient outcomes in the management of COPD, including patient education and steps to minimize exacerbations
Jeffrey Gonzales, PharmD, MS, BCPS, CDCES, PDE-C
Clinical Pharmacy Specialist, Transitions in Care
Pharmacy Department
St. Mary Medical Center
Langhorne, Pennsylvania
Chair, Diabetes Expert Panel
Trinity Health
Livonia, Michigan
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-158-L01-P. The activity is available for CE credit through October 6, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Faculty
Jeffrey Gonzales, PharmD, MS, BCPS, CDCES, PDE-C, has the following relevant financial relationships with commercial interests to disclose:
Stock: Johnson & Johnson, Pfizer
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms